












Background: The argument for financing 
therapeutic community-based drug rehabilitation 
programs for inmates is compelling. Numerous studies 
have established the positive effect of such treatment on 
reducing recidivism, especially treatment based on the 
therapeutic community model. Methods: This quasi-
experimental retrospective cohort study examined the 
impact of therapeutic community-based drug 
rehabilitation programs on recidivism amongst drug 
inmates released from the national prison of Malta 
between 2005 and 2008 (i.e. “the reference period”). An 
experimental group consisting in all drug inmates who 
participated in at least one program during the time spent 
in prison for a conviction that ended during the reference 
period was compared to two comparison groups of 
inmates who did not attend such a program or who had 
attended in the past. Chi-square tests and ANOVA were 
employed in the analysis. 
Results: There was no statistically significant 
difference (p<0.05) between the three groups with 
regard to sex, age on admission and occupation but there 
was a highly significant difference with regard to the 
number of previous convictions, prison-basedopioid 
substitution treatment (given to all inmatesconvicted for 
heroin-related offences) and prison-based psychiatric 
treatment. On fitting a generalized linear model with a 
logit link function to control for opioid substitution 
treatment and the number of previous convictions it 
emerged that the difference between groups was not 






Conclusion: Participation of inmates in 
therapeutic community-based drug rehabilitation 
programs did not in itself emerge as a significant 
predictor of recidivism. In this regard, possible 
limitations that may have contributed to the lack of 
significant results were discussed. Inmates who were not 
administered any opioid substitution treatment (i.e. 
corresponding to all those who were incarcerated for 
drug offences other than heroin) were 74% less likely to 
reoffend compared to those who were given methadone 
or tramadol. Moreover, the likelihood of recidivism was 




therapeutic community-based rehabilitation, 




p: Probability value, CI: confidence interval, sig: 
significance, CCF: Corradino Correctional Facility 
 
Background 
 Malta has often been described as “the Jewel of 
the Mediterranean” and a heaven for locals and 
tourists alike. However, beneath its impressive 
exterior and in sharp contrast with its idyllic 
lifestyle lies a serious social phenomenon: drug 
abuse.  Prevalence of drug use amongst adults 
reaches 14% amongst those aged 18-24 years.1 
Besides the well-known harmful effects on one’s 
health and welfare, substance misuse has serious 
repercussions on society such as the strain on public 
finances spent on medical interventions, loss of 
production, social benefits, court proceedings, etc. 
Even during these challenging times of 
financial crisis, the argument for financing 
therapeutic community-based drug rehabilitation 
programs for inmates is compelling because 
research has shown that these have a positive effect 
on reducing recidivism.2-5 The main goals of 
treatment in a therapeutic community-based 
program center around a radical change in the 
person’s lifestyle including moderation, self-
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restraint, abstinence, removal of anti-social 
behaviour and fostering of pro-social values and 
conduct.6  
Corradino Correctional Facility (CCF)is the 
only correctional institution in Malta and houses all 
people who have been remanded in custody or 
convicted by the local courts. Inmates (on drug-
related offences) who satisfy a number of criteria 
and pass an assessment by the Prison Substance 
Abuse Assessment Board are given permission to 
attend a drug rehabilitation program for the rest of 
their custodial sentence which must not exceed two 
years. There are three such programs currently in 
operation in Malta: the “New Hope” program 
operated by the Caritas Malta Foundation (part 
funded by the Government), the prison-based 
Substance Abuse Therapeutic Unit and the “Santa 
Marija” program operated by Agenzija Sedqa. 
These programs differ in regime and intervention 
approach but are all based on the therapeutic 
community model. The residential phase 
corresponds to the period of the remaining prison 
sentence. Participation is voluntary but subject to 
strict rules. Notwithstanding the potentially crucial 
benefits to inmates and society at large and the 
significant expenditure incurred, the use and impact 
of these programmes is not monitored in an 
extensive or systematic manner and no study has 
ever been undertaken which examines their efficacy 
in preventing recidivism.  
The main purpose of this study was to 
determine the efficacy, or otherwise, of the three 
local drug rehabilitation programs in reducing 
recidivism amongst drug inmates at CCF. It also 
sought to identify predictors and risk factors for 
reoffending with implications for future risk 
management. 
Recidivism in this study was defined as any 
offence (i.e. not necessarily drug-related offences) 
committed after release from CCF during the 
reference period for which the offender had been 
given a conviction by the Maltese Courts 
necessitating a custodial sentence and re-entry into 
prison. Convictions resulting in a conditional 
discharge, probation or suspended sentences were 
not taken into consideration. 
 
Literature Review 
 The literature (consisting of studies conducted 
almost exclusively in the US which is unsurprising 
given that therapeutic communities originated there) 
contains concrete evidence pointing towards the 
effectiveness of therapeutic community-based drug 
rehabilitation programs on reducing recidivism 
amongst inmates with a history of drug abuse and 
drug-related convictions.2-5 However a common 
point of criticism is that studies that demonstrate 
such effectiveness are methodologically weak. 
Moreover, the benefits of such treatment in 
reducing drug relapse are still unclear at best. 
In a meta-analytic study conducted in 2007, the 
authors examined the effectiveness of five types of 
prison-based drug treatment programs including 
those based on the therapeutic-community model in 
reducing recidivism and drug use.2 It was found that 
in six out of seven evaluations, inmates who 
attended therapeutic-community based programs 
recidivated less than those who did not. The overall 
mean-weighted effect size was 0.133 (p=0.025). 
This finding was consistent despite changes in any 
methodological variations or changes in sample 
sizes or the specific features of the programmes. 
The authors also analysed ten studies that explored 
the relationship between residential therapeutic-
community based programmes and recidivism and 
found that these generated a mean odds ratio of 1.30 
(95% CI 1.10–1.76) for recidivism outcomes thus 
proving the effectiveness of such programs in that 
regard. Interestingly, the association between 
participation in the programmes and lower rates of 
recidivism remained strong irrespective of factors 
such as age, gender, type of offence and coercion-
based participation. There were however mixed 
results with regard to the effect of therapeutic-
community based programmes on drug relapse. 
Two out of four studies analysed in the study found 
that inmates who participated in prison therapeutic-
community based programmes had lower rates of 
drug relapse when compared to those that did not, 
while the other two evaluations found the exact 
opposite. The overall mean odds ratio of these four 
studies was 1.02 (95% CI 0.48 – 2.15) thus 
indicating no difference. The authors emphasise the 
fact that most of the evaluations analysed in their 
study were methodologically weak. In fact, 20% of 
such evaluations were classified as weak quasi-
experiments, 43% as standard quasi-experiments, 
30% as rigorous quasi-experiments and 7% as 
experimental designs. According to the authors, 
there is therefore a possibility that being 
methodologically weak, the available research 
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based prison programmes on recidivism and there 
may be alternative explanations for reductions in 
recidivism other than those due to the positive 
effects of the programmes. 
In another study, the author analysed the 
outcomes after release from prison over a period 
spanning five years post-release for 2,809 inmates 
who had participated in therapeutic community-
based substance misuse treatment programs or 
control groups in a number of correctional facilities 
in Pennsylvania, US between January and 
November 2000.3 It was found that participation in 
a therapeutic community-based program had a 
strongly significant effect on reducing recidivism 
over a five year post-release period (p<0.05) and 
that this was independent of community aftercare. 
The impact on re-arrest rates was slightly 
significant (p<0.09) while that on drug relapse was 
negligible (p>.10). The author also found that with 
regard to two of the three analysed outcomes (i.e. 
recidivism and drug relapse), the severity of 
previous offences had no impact on recidivism and 
that employment after release from prison was the 
strongest predictor variable amongst all the 
outcomes.  
The literature review makes a strong case for 
the existence of other predictor variables that have a 
significant effect on reducing recidivism. The 
likelihood of recidivism was found to be almost one 
and a half times more for each additional prior 
incarceration (p=0.002).7 Post-release employment3, 
stable housing8, and the number of prior arrests9,3,5, 
were reported to be significant to strong predictor 
variables of the outcome of recidivism. Inmates 
with co-existing disorders8, and those whose drug 
problem was more severe or whose drug of choice 
was heroin,10 are also more likely to recidivate. It is 
also reported that it is significantly less likely for 
female inmates who undertake prison-based 
treatment to recidivate than male inmates and the 
latter were reconvicted significantly sooner than 
their female counterparts.8-9 It has also been 
reported that retention is a significant predictor of 
long-term success and that the effects of 
participation in therapeutic community-based 
programs on recidivism are most consistent for 
treatment completers rather than for dropouts.11 
 
Methodology 
 This was a quasi-experimental retrospective 
cohort study that compared recidivism outcomes for 
three groups of drug inmates. Recidivism was 
defined as any offence committed between release 
from CCF (limited to release during the reference 
period) until December 2012, for which the 
offender had been convicted by the Maltese Courts 
and given an effective custodial sentence. Existing 
data consisting of electronic files maintained and 
kept at CCF was gathered from three groups of 
inmates having a history of substance abuse all of 
whom were released from CCF during the reference 
period.  
The total sample size consisted of 361 inmates 
who were serving custodial sentences for drug-
related offences. Group 1 consisted of all inmates 
who did not participate in any therapeutic 
community-based drug rehabilitation program 
during the time spent in prison for a conviction that 
ended during the reference period but who had 
participated in any such program in the past (n=27). 
Group 2 consisted of all inmates who never 
participated in any such program (n=229). Group 3 
consisted of all inmates who participated in at least 
one of such programs during the time spent in 
prison for a conviction that ended during the 
reference period (n=105).  
The covariate predictors of sex, age on 
admission, age at first conviction, occupation, 
prison-based psychiatric treatment, prison-based 
opioid substitution treatment and the number of 
prior incarcerations were included in the analysis 
since these could possibly be predictive of the 
outcome under study as evidenced in the literature 
review.  Other factors found to predict recidivism in 
the literature review such as social support, 
educational level, participation in aftercare and 
duration of post-release period from prison were not 
available for inclusion in the analysis. 
Prison-based opioid substitution treatment is 
the replacement of heroin under medical 
supervision with a longer acting but less euphoric 
opioid such as methadone or tramadol. For the 
purpose of this study, all inmates who were 
incarcerated for heroin-related offences were 
administered opioid substitution treatment, while 
the rest (i.e. incarcerated for other drug-related 
offences) were not administered such treatment. 
 
Statistical analysis 
 PASW Statistics version 18.0.0 was used for 
data analysis. Pearson chi-square tests, Fisher’s 
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logit link function were used to compare categorical 
variables (including sex, occupation, prison-based 
opioid substitution treatment, prison-based 
psychiatric treatment and the number of previous 
convictions) between groups, ascertain any possible 
relationship between recidivism and such variables 
and ultimately test the null hypothesis that 
offenders with substance-use disorder who 
participate in a therapeutic community-based drug 
rehabilitation program are not less likely to reoffend 
than offenders who do not participate in such 
programs.  An alpha level of 0.05 for all statistical 
tests was used. 
 Table 1 presents a summary of the 
descriptive data for the study participants on a 
number of variables such as, gender, age on 
admission, age at first conviction, occupation, 
previous convictions, prison-based opioid 
substitution treatment and prison-based psychiatric 
treatment. Group 2 had the largest number of no 
previous convictions. In fact, 5.1% of group 1, 
72.2% of group 2 and 22.8% of group 3 had no 
previous convictions. In Group 1, 74% were on 
methadone, 7% on tramadol only and only 18% 
were not administered any opioid-substitution 
treatment. In Group 2, 52% were on methadone, 
11% were on tramadol only and 37% were on no 
opioid-substitution treatment. No opioid 
substitution treatment was most common in Group 
2. In Group 3, 74% were on methadone, 10% were 
on tramadol only and 16% were on no opioid-
substitution treatment. Inmates in Group 2 were the 
least likely to be on psychiatric treatment. In 
Groups 1 and 3, 89% were on psychiatric treatment, 




Table 1: Summary of descriptive data in relation to sex, age on admission, age at first conviction, occupation, 


































Variable Group 1 Group 2 Group 3 Total 
 
(n = 27) (n = 229) (n = 105) (N = 361) 
Sex  
# Males (%) 27 (100) 213 (93) 98 (93) 338 (94) 
# Females (%) 0 (0) 16 (7) 7 (7) 23 (6) 
Age on admission Mean (SD) 29.85 (5.88) 29.5 (9.15) 28.21 (7.4) 29.15 (8.47) 
Age at 1st conviction Mean (SD) 25.11 (5.15) 27.31 (7.96) 24.46 (5.85) 26.31 (7.33) 
Occupation  
# Unemployed (%) 26 (96) 177 (77) 82 (78) 285 (79) 
# Employed (%) 1 (4) 52 (33) 23 (22) 76 (21) 
Previous convictions  a # 0 (%) 12 (44) 171 (75) 54 (51) 237 (66) 
# 1 (%) 3 (11) 18 (8) 22 (21) 43 (12) 
# 2 (%) 7 (26) 16 (7) 9 (9) 32 (9) 
# 3 (%) 5 (19) 24 (10) 20 (19) 49  (13) 
Drug treatmentb # No opioid substitution treatment (%) 5 (19) 84 (37) 17 (16) 106 (29) 
# On tramadol only (%) 2 (7) 25 (11) 10 (10) 37 (10) 
# On methadone with or without tramadol (%) 20 (74) 120 (52) 78 (74) 218 (61) 
Psych treatmentc # No psychiatric treatment (%) 3 (11) 70 (31) 11 (10) 84 (23) 
# On psychiatric treatment (%) 24 (89) 159 (69) 94 (90) 277 (77) 
 
a. Thiscategorical variable was coded as follows: 0 = no previous convictions, 1 = one previous conviction, 2 = two 
previous convictions and 3 = three or more previous convictions. 
b. In-prison opioid substitution treatment 
c. In-prison psychiatric treatment 
 
Notes: Group 1 - inmates who attended a program in the past, Group 2 - inmates who never participated in a program, Group 3 - 














 There was no statistically significant 
difference between groups with regard to gender, 
p=0.537 (2-tailed), age on admission, F (2, 
N=358)=9.38, p=0.392 and occupation, χ2 (2, 
N=361)=5.31, p=0.070. There was a highly 
significant difference between groups on a number 
of previous convictions χ2 (6, N=361)=32.51, 
p<0.001, prison-based opioid substitution 
treatment χ2 (4, N=361)=18.44, p=0.001, and 
prison-based psychiatric treatment χ2 (2, 
N=361)=18.69, p<0.001. Collinearity was 
observed between opioid substitution treatment 
and psychiatric treatment. In fact, 89% of inmates 
who were administered opioid substitution 
treatment were also on psychiatric treatment, 
whilst only 46% of those who were not having 
opioid substitution treatment were on psychiatric 
treatment. It was thus decided that psychiatric 
treatment should be eliminated from further 
statistical analysis. 
A generalized linear model with a logit link 
function was thus used to compare the reoffence 
rate between groups when controlling for opioid 
substitution treatment and the number of previous 
convictions (Table 2). It emerged that the 
difference between groups was not significant 
when controlling for opioid substitution treatment 
and number of previous convictions and thus the 
null hypothesis was not rejected. It was found that 
those inmates who were not administered any 
opioid substitution treatment were 74% less likely 
to reoffend compared to those who were given 
methadone or tramadol.  Interestingly, the number 
of previous convictions emerged as a significant 
predictor of recidivism. Results indicated that the 
likelihood of recidivism was 1.7 times greater for 
each additional prior incarceration (p<0.001). 
 
Table 2: Parameter Estimates - Comparison of reoffence rate between groups when controlling for 
opioid substitution treatment and number of previous convictions. 
 
a. Set to zero because this parameter is redundant. 
b. Fixed at the displayed value. 
c. Number of previous convictions 
d. No prison-basedopioid substitution treatment 
e. In-prison opioid substitution treatment - on tramadol only 
f. In-prison opioid substitution treatment - on methadone treatment with or without tramadol 
 
Notes: Group 1 - inmates who attended a program in the past, Group 2 - inmates who never participated in a program, Group 3 - 
inmates who participated in a program during reference period 
 
Discussion 
The null hypothesis in this study was not 
rejected when controlling for opioid substitution 
treatment and the number of previous convictions. 
Quite surprisingly recidivism was higher in the 
group that attended a program (55.2%) than in the 
group who never participated in a program 
(44.8%). Thus participation in a drug rehabilitation 
program was not a significant predictor of 
recidivism for inmates at the CCF in this study. 
This result was not consistent with studies outlined 




B Std. Error 
95% Wald CI Hypothesis Test Exp(B) 
95% Wald CI for 
Exp(B) 
Lower Upper Wald x2 df Sig.  Lower Upper 
Group  1 .665 .4985 -.312 1.642 1.781 1 .182 1.945 .732 5.167 
Group  2 -.088 .2638 -.605 .429 .112 1 .738 .915 .546 1.535 
Group  3  . . . . . . 1 . . 
PREVc .571 .1177 .341 .802 23.561 1 .000 1.770 1.406 2.230 
[REPL=0]d -1.329 .2829 -1.883 -.774 22.061 1 .000 .265 .152 .461 
[REPL=1]e .159 .3773 -.581 .898 .177 1 .674 1.172 .559 2.455 
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that the limitations of this study (particularly the 
study design and the small sample size) 
contributed significantly to influence statistical 
results leading to a failure in rejecting a null 
hypothesis that was false.  
In keeping with findings from other studies 
that reported that inmates whose primary drug of 
choice was heroin were more likely to recidivate, 
it was found that those inmates who were not 
administered any opioid substitution treatment (i.e. 
consisting only of those inmates who were 
incarcerated for drug-related offences other than 
heroin) were 74% less likely to reoffend compared 
to those who were given methadone or tramadol.10 
Also, the finding that the likelihood of recidivism 
was almost two times greater for each additional 
prior incarceration replicated the findings of 
earlier studies.12-14 However age on admission 
(p=0.392) was found not to be a significant 
predictor of recidivism despite the consistent 
finding reported in other studies that younger 
offenders were most likely to recidivate.3,8-10 
 
Limitations 
The major limitations of this study are the 
study design, the small sample size and the use of 
recidivism as an outcome measure. 
Being a quasi-experimental design, this work 
studied pre-established groups of participants rather 
than participants that have been randomly assigned 
to experimental conditions. In other words, 
participants are not randomly assigned to levels of 
the independent variable (i.e. recidivism). This type 
of design was appropriate and indeed made 
necessary because the author used existing archived 
data kept at CCF and thus it was neither possible 
nor feasible to randomly assign individuals to 
groups. The main problem with a quasi-
experimental retrospective design (as against a true 
experimental design) is that there is a real risk that 
results could be due to one or more confounding 
variables. Quasi-experiments tend to have lower 
internal validity in comparison to true experiments 
and it may be difficult to interpret results as group 
equivalence is not assumed. In this study, the 
analysis included two comparison groups to help 
control for some of the variance. This 
notwithstanding, selection bias remains a real threat 
to the internal validity of this study. A number of 
covariate predictor variables that were available to 
include in the analysis some of whom were 
identified in the literature review (including age on 
admission, number of prior incarcerations, prison-
based psychiatric treatment, prison-based opioid 
substitution treatment and occupational status) were 
entered so as to adjust for possible differences 
between the groups on available variables. However 
other factors found to predict recidivism in the 
literature review such as social support, educational 
level, participation in aftercare and duration of post-
release period from prison were not available for 
inclusion in the analysis. Also the retrospective 
design of the study meant that the author did not 
have control on the choice, accuracy or 
completeness of the data presented to her.  
 Another limitation of this study is the sample 
size as well as the disproportionate sizes between 
Group 1 and the other two groups. While the 
sample size in the present study (361 inmates) was 
deemed modest but adequate for the proposed study 
design, the possibility that larger samples might 
have led to significant differences in recidivism 
rates cannot be discounted. Indeed, studies 
identified in the literature review that reported 
significant treatment effects utilised larger samples 
ranging from 690,9 to 715,15 and 1,343 inmates.16 
Furthermore, using recidivism as an outcome 
measure and as defined in this study has a number 
of possible limitations.  For instance, inmates 
released during the reference period who reoffended 
and were convicted by Court but awarded non-
custodial sentences were not considered recidivists. 
On the other hand, an inmate who was released 
during the reference period, did not reoffend but 
was convicted by Court and awarded a custodial 
sentence for a crime that was committed in the past 
was considered a recidivist. This means that 
recidivism rates at least within the scope of this 
study may be inaccurate and/or misleading since a 
decrease or increase in such rates might not 
necessarily reflect a genuine decrease or increase in 
reoffending but might reflect unrelated factors such 
as commission of less detectable offences, or more 
likely, delays in the processing and conviction of 
offenders for pending charges (unfortunately a 
common occurrence in the local justice system). Also, 
using recidivism in general as a performance indicator 
does not take into consideration the seriousness of the 
crime for which an inmate is re-incarcerated. 
Unfortunately, data concerning the types and nature of 
crimes for which inmates were re-incarcerated was 














 The present study failed to replicate the 
findings of a large number of other studies that 
participation in drug rehabilitation programs based 
on the therapeutic community model is a 
significant predictor of recidivism. While the 
limitations of the study, especially the study design 
and modest sample size, are important 
considerations when evaluating its outcomes, a 
possibility that cannot be excluded is that the 
prison inmate programs offered to inmates at the 
Corradino Correctional Facility are not 
accomplishing their intended objectives and goals 
at least in terms of ensuring that clients do not 
return to prison. On the other hand, lack of 
supervision, support and community after care 
post-release from the programs might be defining 
factors that influence and possibly eliminate the 
possible benefits ensuing to inmates from 
participation. 
Future research should ideally be conducted 
using a large sample (as well as proportionate 
groups) and a different design, perhaps 
incorporating a longitudinal perspective that 
includes face to face interviews with inmates and 
analyses of the influence on treatment outcomes of 
factors such as variations between the programs, 
the duration of such programs, inmates’ 
characteristics, post-release psycho-social stressors 
and confounding variables such as social support, 
employment status and participation in aftercare. 
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